Fei Luo

4.9k citations

135 papers · 3.8k · h-index 36

Impact in

Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Genetics top 2%
- Mesenchymal stem cell research

Papers in

Molecular Biology 70
- Bone Metabolism and Diseases 22
- Circular RNAs in diseases 13
Cancer Research 29
- MicroRNA in disease regulation 21

Co-authors: Jianzhong Xu (51 shared papers)Tianyong Hou (36 shared papers)Ce Dou (32 shared papers)Shiwu Dong (29 shared papers)Qizhan Liu (15 shared papers)Zhao Xie (23 shared papers)Junchao Xue (10 shared papers)Hui Xu (10 shared papers)
Journals: Tissue Engineering Part A (6 papers)Cell Death and Disease (4 papers)Advanced Science (4 papers)Toxicology and Applied Pharmacology (4 papers)Scientific Reports (3 papers)
Partner nations: China United States South Korea

In The Last Decade

Fei Luo

129 papers receiving 3.8k citations

Peers

Countries citing papers authored by Fei Luo

Since Specialization

Citations

This map shows the geographic impact of Fei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Luo more than expected).

Fields of papers citing papers by Fei Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Luo. The network helps show where Fei Luo may publish in the future.

Co-authors

The 25 scholars most cited alongside Fei Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fei Luo Line = papers co-authored together Fei Luo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells Cancer Letters ·Yi Liu, Fei Luo, Bairu Wang, Huiqiao Li, Yue Xu, Xinlu Liu, Le Shi, Xiaolin Lü, Wenchao Xu, Lu Lu, Yu Qin, Quanyong Xiang, Qizhan Liu	2015	237
2	The immunomodulatory activity of human umbilical cord blood‐derived mesenchymal stem cells in vitro Immunology ·Meng Wang, Yuan Yang, Dongming Yang, Fei Luo, Wenjie Liang, Shuquan Guo, Jianzhong Xu	2008	195
3	Changing expression profiles of lncRNAs, mRNAs, circRNAs and miRNAs during osteoclastogenesis Scientific Reports ·Ce Dou, Zhen Cao, Bo Yang, Ning Ding, Tianyong Hou, Fei Luo, Fei Kang, Jian‐Mei Li, Xiaochao Yang, Hong Jiang, Junyu Xiang, Hongyu Quan, Jianzhong Xu, Shiwu Dong	2016	158
4	Exosomal microRNA-21 derived from bronchial epithelial cells is involved in aberrant epithelium-fibroblast cross-talk in COPD induced by cigarette smoking Theranostics ·Hui Xu, Ling Min, Junchao Xue, Xiangyu Dai, Qian Sun, Chao Chen, Yi Liu, Liang Zhou, Jianping Liu, Fei Luo, Qian Bian, Qizhan Liu	2018	158
5	Exosomal circRNA_100284 from arsenite-transformed cells, via microRNA-217 regulation of EZH2, is involved in the malignant transformation of human hepatic cells by accelerating the cell cycle and promoting cell proliferation Cell Death and Disease ·Xiangyu Dai, Chao Chen, Qianlei Yang, Junchao Xue, Xiong Chen, Baofei Sun, Fei Luo, Xinlu Liu, Tian Xiao, Hui Xu, Qian Sun, Aihua Zhang, Qizhan Liu	2018	149
6	Estrogen Deficiency–Mediated M2 Macrophage Osteoclastogenesis Contributes to M1/M2 Ratio Alteration in Ovariectomized Osteoporotic Mice Journal of Bone and Mineral Research ·Ce Dou, Ning Ding, Chunrong Zhao, Tianyong Hou, Fei Kang, Zhen Cao, Chuan Liu, Yun Bai, Qijie Dai, Qinyu Ma, Fei Luo, Jianzhong Xu, Shiwu Dong	2017	128
7	NF-kB-regulated exosomal miR-155 promotes the inflammation associated with arsenite carcinogenesis Cancer Letters ·Chao Chen, Fei Luo, Xinlu Liu, Lu Lu, Hui Xu, Qianlei Yang, Junchao Xue, Le Shi, Jun Li, Aihua Zhang, Qizhan Liu	2016	95
8	Graphene‐Based MicroRNA Transfection Blocks Preosteoclast Fusion to Increase Bone Formation and Vascularization Advanced Science ·Ce Dou, Ning Ding, Fei Luo, Tianyong Hou, Zhen Cao, Yun Bai, Chuan Liu, Jianzhong Xu, Shiwu Dong	2017	92
9	IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis Cell Death and Disease ·Mengmeng Liang, Qinyu Ma, Ning Ding, Fei Luo, Yun Bai, Fei Kang, Xiaoshan Gong, Rui Dong, Jingjin Dai, Qijie Dai, Ce Dou, Shiwu Dong	2019	76
10	Umbilical Cord Wharton's Jelly: A New Potential Cell Source of Mesenchymal Stromal Cells for Bone Tissue Engineering Tissue Engineering Part A ·Tianyong Hou, Jianzhong Xu, Xuehui Wu, Zhao Xie, Fei Luo, Zehua Zhang, Ling Zeng	2009	73
11	Osteoclast-derived apoptotic bodies couple bone resorption and formation in bone remodeling Bone Research ·Qinyu Ma, Mengmeng Liang, Yutong Wu, Fei Luo, Zaisong Ma, Shiwu Dong, Jianzhong Xu, Ce Dou	2021	73
12	Circ100284, via miR-217 regulation of EZH2, is involved in the arsenite-accelerated cell cycle of human keratinocytes in carcinogenesis Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Junchao Xue, Yang Liu, Fei Luo, Xiaolin Lü, Hui Xu, Xinlu Liu, Lu Lu, Qianlei Yang, Chao Chen, Weimin Fan, Qizhan Liu	2017	70
13	Bone-targeted pH-responsive cerium nanoparticles for anabolic therapy in osteoporosis Bioactive Materials ·Ce Dou, Jian‐Mei Li, Jian He, Fei Luo, Yu Tao, Qijie Dai, Yueqi Chen, Jianzhong Xu, Xiaochao Yang, Shiwu Dong	2021	69
14	Arsenite evokes IL-6 secretion, autocrine regulation of STAT3 signaling, and miR-21 expression, processes involved in the EMT and malignant transformation of human bronchial epithelial cells Toxicology and Applied Pharmacology ·Fei Luo, Yue Xu, Ling Min, Yue Zhao, Wenchao Xu, Liang Xiao, Rongrong Jiang, Bairu Wang, Qian Bian, Qizhan Liu	2013	67
15	KAT6A Acetylation of SMAD3 Regulates Myeloid‐Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple‐Negative Breast Cancer Advanced Science ·Bo Yu, Fei Luo, Bowen Sun, Wenxue Liu, Qiqi Shi, Shi‐Yuan Cheng, Ceshi Chen, Guoqiang Chen, Yanxin Li, Haizhong Feng	2021	64
16	Effects of Pulsed Electromagnetic Field Frequencies on the Osteogenic Differentiation of Human Mesenchymal Stem Cells Orthopedics ·Fei Luo, Tianyong Hou, Zehua Zhang, Zhao Xie, Xuehui Wu, Jianzhong Xu	2012	64
17	IL-8 Enhances Therapeutic Effects of BMSCs on Bone Regeneration via CXCR2-Mediated PI3k/Akt Signaling Pathway Cellular Physiology and Biochemistry ·Aijun Yang, Yanzhu Lu, Junchao Xing, Zhilin Li, Xiaolong Yin, Ce Dou, Shiwu Dong, Fei Luo, Zhao Xie, Tianyong Hou, Jianzhong Xu	2018	62
18	Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis Tumor Biology ·Le Shi, Fan Yang, Fei Luo, Yi Liu, Feng Zhang, Meijuan Zou, Qizhan Liu	2016	54
19	Circ008913,viamiR-889 regulation of DAB2IP/ZEB1, is involved in the arsenite-induced acquisition of CSC-like properties by human keratinocytes in carcinogenesis Metallomics ·Tian Xiao, Junchao Xue, Ming Shi, Chao Chen, Fei Luo, Hui Xu, Xiong Chen, Baofei Sun, Qian Sun, Qianlei Yang, Xiangyu Dai, Aihua Zhang, Huanwen Tang, Qizhan Liu	2018	54
20	Exosomal miR-21 derived from arsenite-transformed human bronchial epithelial cells promotes cell proliferation associated with arsenite carcinogenesis Archives of Toxicology ·Yue Xu, Fei Luo, Yi Liu, Le Shi, Xiaolin Lü, Wenchao Xu, Qizhan Liu	2014	53

About Fei Luo

Fei Luo is a scholar working on Molecular Biology, Cancer Research, Biomedical Engineering, Surgery and Epidemiology, having authored 135 papers that have together received 3.8k indexed citations. Recurring topics across this work include Bone Tissue Engineering Materials (24 papers), Bone Metabolism and Diseases (22 papers), MicroRNA in disease regulation (21 papers), Circular RNAs in diseases (13 papers), Bone fractures and treatments (13 papers), Mesenchymal stem cell research (12 papers), Orthopedic Infections and Treatments (12 papers) and Periodontal Regeneration and Treatments (10 papers). The work is most often cited by research in Cancer Research (1.2k citations), Genetics (404 citations), Molecular Biology (2.2k citations), Orthopedics and Sports Medicine (190 citations) and Urology (121 citations). Fei Luo has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jianzhong Xu, Tianyong Hou, Ce Dou, Shiwu Dong, Qizhan Liu, Zhao Xie, Junchao Xue, Hui Xu, Xinlu Liu and Ning Ding. Their work appears in journals such as Tissue Engineering Part A, Cell Death and Disease, Advanced Science, Toxicology and Applied Pharmacology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Fei Luo

Impact in

Papers in i

In The Last Decade

Fei Luo

Peers

Countries citing papers authored by Fei Luo

Fields of papers citing papers by Fei Luo

All Works

About Fei Luo

Explore authors with similar magnitude of impact

Papers in